UPDATE: BASF-LYNX Gets Name Change, 10M Euro Cash Infusion in Restructuring Effort | GenomeWeb

This story has been updated from a previous version.

NEW YORK, Nov. 12 – BASF-LYNX, the joint venture between German chemicals giant BASF and Lynx Therapeutics, an American maker of DNA profiling technologies, said Monday it had been renamed Axaron Bioscience as part of a restructuring program designed to give the company more independence in the marketplace.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.